Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

552 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Risk Factors of Complications from Central Bisectionectomy (H458) for Hepatocellular Carcinoma: A Multi-Institutional Single-Arm Analysis.
Nanashima A, Eguchi S, Hisaka T, Kawasaki Y, Yamashita YI, Ide T, Kuroki T, Yoshizumi T, Kitahara K, Endo Y, Utsunomiya T, Kajiwara M, Sakoda M, Okamoto K, Nagano H, Takami Y, Beppu T. Nanashima A, et al. Among authors: takami y. Cancers (Basel). 2023 Mar 13;15(6):1740. doi: 10.3390/cancers15061740. Cancers (Basel). 2023. PMID: 36980626 Free PMC article.
Prognostic Impact of Preoperative Lymph Node Enlargement in Intrahepatic Cholangiocarcinoma: A Multi-Institutional Study by the Kyushu Study Group of Liver Surgery.
Adachi T, Eguchi S, Beppu T, Ueno S, Shiraishi M, Okuda K, Yamashita Y, Kondo K, Nanashima A, Ohta M, Takami Y, Noritomi T, Kitahara K, Fujioka H. Adachi T, et al. Among authors: takami y. Ann Surg Oncol. 2015 Jul;22(7):2269-78. doi: 10.1245/s10434-014-4239-8. Epub 2015 Jan 13. Ann Surg Oncol. 2015. PMID: 25582737
Anterior approach for right hepatectomy with hanging maneuver for hepatocellular carcinoma: a multi-institutional propensity score-matching study.
Beppu T, Imai K, Okuda K, Eguchi S, Kitahara K, Taniai N, Ueno S, Shirabe K, Ohta M, Kondo K, Nanashima A, Noritomi T, Shiraishi M, Takami Y, Okamoto K, Kikuchi K, Baba H, Fujioka H. Beppu T, et al. Among authors: takami y. J Hepatobiliary Pancreat Sci. 2017 Mar;24(3):127-136. doi: 10.1002/jhbp.431. J Hepatobiliary Pancreat Sci. 2017. PMID: 28181419
Surgical management of recurrent intrahepatic cholangiocarcinoma: predictors, adjuvant chemotherapy, and surgical therapy for recurrence: A multi-institutional study by the Kyushu Study Group of Liver Surgery.
Yamashita YI, Shirabe K, Beppu T, Eguchi S, Nanashima A, Ohta M, Ueno S, Kondo K, Kitahara K, Shiraishi M, Takami Y, Noritomi T, Okamoto K, Ogura Y, Baba H, Fujioka H. Yamashita YI, et al. Among authors: takami y. Ann Gastroenterol Surg. 2017 Jul 20;1(2):136-142. doi: 10.1002/ags3.12018. eCollection 2017 Jun. Ann Gastroenterol Surg. 2017. PMID: 29863136 Free PMC article.
Clinicopathological characteristics of combined hepatocellular cholangiocarcinoma from the viewpoint of patient prognosis after hepatic resection: High rate of early recurrence and its predictors.
Yamashita YI, Aishima S, Nakao Y, Yoshizumi T, Nagano H, Kuroki T, Takami Y, Ide T, Ohta M, Takatsuki M, Nanashima A, Ishii F, Kitahara K, Iino S, Beppu T, Baba H, Eguchi S. Yamashita YI, et al. Among authors: takami y. Hepatol Res. 2020 Jul;50(7):863-870. doi: 10.1111/hepr.13507. Epub 2020 May 12. Hepatol Res. 2020. PMID: 32335986
Trends in hepatocellular carcinoma incident cases in Japan between 1996 and 2019.
Nakano M, Yatsuhashi H, Bekki S, Takami Y, Tanaka Y, Yoshimaru Y, Honda K, Komorizono Y, Harada M, Shibata M, Sakisaka S, Shakado S, Nagata K, Yoshizumi T, Itoh S, Sohda T, Oeda S, Nakao K, Sasaki R, Yamashita T, Ido A, Mawatari S, Nakamuta M, Aratake Y, Matsumoto S, Maeshiro T, Goto T, Torimura T. Nakano M, et al. Among authors: takami y. Sci Rep. 2022 Jan 27;12(1):1517. doi: 10.1038/s41598-022-05444-z. Sci Rep. 2022. PMID: 35087153 Free PMC article.
Comparison of Efficacy and Safety of Atezolizumab Plus Bevacizumab and Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
Niizeki T, Tokunaga T, Takami Y, Wada Y, Harada M, Shibata M, Nakao K, Sasaki R, Hirai F, Shakado S, Yoshizumi T, Itoh S, Yatsuhashi H, Bekki S, Ido A, Mawatari S, Honda K, Sugimoto R, Senju T, Takahashi H, Kuwashiro T, Maeshiro T, Nakamuta M, Aratake Y, Yamashita T, Otsuka Y, Matsumoto S, Sohda T, Shimose S, Murotani K, Tanaka Y. Niizeki T, et al. Among authors: takami y. Target Oncol. 2022 Nov;17(6):643-653. doi: 10.1007/s11523-022-00921-x. Epub 2022 Oct 22. Target Oncol. 2022. PMID: 36272060 Free PMC article.
552 results